Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

NCT01822691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: INCB024360

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]